Trials / Active Not Recruiting
Active Not RecruitingNCT02817659
To Determine Tolerability to Glucagon Infusion in Obese Subjects
A Pilot Study to Determine Tolerability to Glucagon Infusion in Obese Subjects
- Status
- Active Not Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- AdventHealth Translational Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
To further understand the tolerability of glucagon.
Detailed description
To determine the tolerability of glucagon infusion administered in an escalating step-wise manner in healthy obese subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Glucagon | Glucagon infusion |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2017-01-13
- Completion
- 2026-12-01
- First posted
- 2016-06-29
- Last updated
- 2026-03-30
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT02817659. Inclusion in this directory is not an endorsement.